世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5442
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、変形性関節症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（変形性関節症（詳細不明）、変形性膝関節症、肩変形性関節症、股関節変形性関節症）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・変形性関節症幹細胞治療の市場動向
・企業の競争状況、市場シェア
・変形性関節症幹細胞治療の種類別市場規模（単剤療法、併用療法）
・変形性関節症幹細胞治療の用途別市場規模（変形性関節症（詳細不明）、変形性膝関節症、肩変形性関節症、股関節変形性関節症）
・変形性関節症幹細胞治療の北米市場規模2016-2027（アメリカ、カナダ）
・変形性関節症幹細胞治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・変形性関節症幹細胞治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・変形性関節症幹細胞治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・変形性関節症幹細胞治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Mesoblast、Regeneus、U.S. Stem Cell、Anterogen、Asterias Biotherapeutics）
・結論

Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe.
The expected growth is because of increasing awareness of osteoarthritis and increasing diagnosis rates, rising older population, and increasing cases of obesity. Osteoarthritis is directly related to obesity, with approximately 35% of osteoarthritis patients suffering from obesity.

Market Analysis and Insights: Global Stem Cell Therapy for Osteoarthritis Market
The global Stem Cell Therapy for Osteoarthritis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Therapy for Osteoarthritis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Therapy for Osteoarthritis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Therapy for Osteoarthritis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Therapy for Osteoarthritis market.

Global Stem Cell Therapy for Osteoarthritis Scope and Market Size
Stem Cell Therapy for Osteoarthritis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Osteoarthritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Combination Therapy

Segment by Application
Osteoarthritis (unspecified)
Knee Osteoarthritis
Shoulder Osteoarthritis
Hip Osteoarthritis

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Mesoblast
Regeneus
U.S. Stem Cell
Anterogen
Asterias Biotherapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Osteoarthritis (unspecified)
1.3.3 Knee Osteoarthritis
1.3.4 Shoulder Osteoarthritis
1.3.5 Hip Osteoarthritis
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2016-2027)
2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Regions
2.2.1 Stem Cell Therapy for Osteoarthritis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Share by Regions (2016-2021)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Regions (2022-2027)
2.3 Stem Cell Therapy for Osteoarthritis Industry Dynamic
2.3.1 Stem Cell Therapy for Osteoarthritis Market Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2016-2021)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2016-2021)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2020
3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2016-2021)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2022-2027)

5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2016-2021)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type
6.2.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
6.2.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
6.2.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application
6.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
6.3.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
6.3.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country
6.4.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
6.4.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type
7.2.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
7.2.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
7.2.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application
7.3.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
7.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
7.3.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country
7.4.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
7.4.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type
8.2.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application
8.3.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region
8.4.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type
9.2.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
9.2.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
9.2.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application
9.3.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
9.3.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
9.3.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country
9.4.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
9.4.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type
10.2.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application
10.3.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country
10.4.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Mesoblast
11.1.1 Mesoblast Company Details
11.1.2 Mesoblast Business Overview
11.1.3 Mesoblast Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Mesoblast Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.1.5 Mesoblast Recent Development
11.2 Regeneus
11.2.1 Regeneus Company Details
11.2.2 Regeneus Business Overview
11.2.3 Regeneus Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Regeneus Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.2.5 Regeneus Recent Development
11.3 U.S. Stem Cell
11.3.1 U.S. Stem Cell Company Details
11.3.2 U.S. Stem Cell Business Overview
11.3.3 U.S. Stem Cell Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 U.S. Stem Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.3.5 U.S. Stem Cell Recent Development
11.4 Anterogen
11.4.1 Anterogen Company Details
11.4.2 Anterogen Business Overview
11.4.3 Anterogen Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Anterogen Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.4.5 Anterogen Recent Development
11.5 Asterias Biotherapeutics
11.5.1 Asterias Biotherapeutics Company Details
11.5.2 Asterias Biotherapeutics Business Overview
11.5.3 Asterias Biotherapeutics Stem Cell Therapy for Osteoarthritis Introduction
11.5.4 Asterias Biotherapeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.5.5 Asterias Biotherapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Stem Cell Therapy for Osteoarthritis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Stem Cell Therapy for Osteoarthritis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2016-2021)
Table 8. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2022-2027)
Table 10. Stem Cell Therapy for Osteoarthritis Market Trends
Table 11. Stem Cell Therapy for Osteoarthritis Market Drivers
Table 12. Stem Cell Therapy for Osteoarthritis Market Challenges
Table 13. Stem Cell Therapy for Osteoarthritis Market Restraints
Table 14. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Stem Cell Therapy for Osteoarthritis Market Share by Players (2016-2021)
Table 16. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2020)
Table 17. Ranking of Global Top Stem Cell Therapy for Osteoarthritis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
Table 21. Date of Enter into Stem Cell Therapy for Osteoarthritis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2016-2021)
Table 25. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Stem Cell Therapy for Osteoarthritis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2016-2021)
Table 29. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Mesoblast Company Details
Table 62. Mesoblast Business Overview
Table 63. Mesoblast Stem Cell Therapy for Osteoarthritis Product
Table 64. Mesoblast Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 65. Mesoblast Recent Development
Table 66. Regeneus Company Details
Table 67. Regeneus Business Overview
Table 68. Regeneus Stem Cell Therapy for Osteoarthritis Product
Table 69. Regeneus Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 70. Regeneus Recent Development
Table 71. U.S. Stem Cell Company Details
Table 72. U.S. Stem Cell Business Overview
Table 73. U.S. Stem Cell Stem Cell Therapy for Osteoarthritis Product
Table 74. U.S. Stem Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 75. U.S. Stem Cell Recent Development
Table 76. Anterogen Company Details
Table 77. Anterogen Business Overview
Table 78. Anterogen Stem Cell Therapy for Osteoarthritis Product
Table 79. Anterogen Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 80. Anterogen Recent Development
Table 81. Asterias Biotherapeutics Company Details
Table 82. Asterias Biotherapeutics Business Overview
Table 83. Asterias Biotherapeutics Stem Cell Therapy for Osteoarthritis Product
Table 84. Asterias Biotherapeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 85. Asterias Biotherapeutics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Osteoarthritis Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2020 VS 2027
Figure 5. Osteoarthritis (unspecified) Case Studies
Figure 6. Knee Osteoarthritis Case Studies
Figure 7. Shoulder Osteoarthritis Case Studies
Figure 8. Hip Osteoarthritis Case Studies
Figure 9. Stem Cell Therapy for Osteoarthritis Report Years Considered
Figure 10. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions: 2020 VS 2027
Figure 13. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2022-2027)
Figure 14. Global Stem Cell Therapy for Osteoarthritis Market Share by Players in 2020
Figure 15. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2020
Figure 17. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2016-2021)
Figure 18. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2022-2027)
Figure 19. North America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 21. North America Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 22. North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 23. United States Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 27. Europe Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 28. Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 29. Germany Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Region (2016-2027)
Figure 39. China Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 47. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 48. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 49. Mexico Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 55. Turkey Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Mesoblast Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 59. Regeneus Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 60. U.S. Stem Cell Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 61. Anterogen Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 62. Asterias Biotherapeutics Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年）

Global Cancer Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1071 2021年4月 92Pages
QYResearch社発行の本調査資料では、がん幹細胞（CSC）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）、用途別市場規模（病院、クリニック、医学研究機関、その他）、主要地域別市...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2021-2027
QYR2104Z5441 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、脳室内）、用途別市場規模（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Rheumatoid Arthritis Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5046 2021年4月 93Pages
QYResearch社発行の本調査資料では、関節リウマチ幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種間葉系幹細胞、骨髄移植、脂肪組織幹細胞）、用途別市場規模（病院、外来手術センター、専門診療所）、主要地域別市場規模（北米、アメ...

Global Stem Cell Therapy for Diabetes and Related Conditions Market Size, Status and Forecast 2021-2027
QYR2104Z5440 2021年4月 97Pages
QYResearch社発行の本調査資料では、糖尿病及び関連疾患用幹細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（1型糖尿病、2型糖尿病、糖尿病性足潰瘍、糖尿病性腎症、糖尿病性ニューロパチー）、主要...

世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Animal Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0344 2021年4月 98Pages
QYResearch社発行の本調査資料では、動物用幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（犬用幹細胞治療、馬用幹細胞治療、その他動物）、用途別市場規模（獣医病院、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の犬幹細胞療法市場規模・現状・予測（2021年-2027年）

Global Canine Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1084 2021年4月 92Pages
QYResearch社発行の本調査資料では、犬幹細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種幹細胞、自家幹細胞）、用途別市場規模（獣医病院、獣医クリニック、獣医研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の脂肪由来幹細胞（ADSC）治療市場規模・現状・予測（2021年-2027年）

Global Adipose Derived Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0104 2021年4月 129Pages
QYResearch社発行の本調査資料では、脂肪由来幹細胞（ADSC）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞、同種幹細胞）、用途別市場規模（治療、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の脂肪組織由来幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Adipose Tissue-derived Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0105 2021年4月 133Pages
QYResearch社発行の本調査資料では、脂肪組織由来幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞、同種幹細胞）、用途別市場規模（治療、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の自家幹細胞ベース治療法市場規模・現状・予測（2021年-2027年）

Global Autologous Stem Cell Based Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z0526 2021年4月 93Pages
QYResearch社発行の本調査資料では、自家幹細胞ベース治療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞）、用途別市場規模（神経変性疾患、自己免疫疾患、心血管疾患）、主要地域別市場規模（北米、ア...

世界の変形性膝関節症治療市場規模・現状・予測（2021年-2027年） Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint …
世界の変形性関節症用再生療法市場規模・現状・予測（2021年-2027年） Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market. Market Analysis and Insights: Global Regenerative Therapies for Osteoart…
世界の変形性関節症治療市場規模・現状・予測（2021年-2027年） Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swellin…
世界の変形性関節症鎮痛剤市場規模・現状・予測（2021年-2027年） Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis. Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Re…
世界の変形性関節症治療薬市場規模・現状・予測（2021年-2027年） Osteoarthritis is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and l…